ANGO vs IR · rev $292.5M vs P/E 49, rev $7.24B
AngioDynamics Inc (ANGO) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
ANGO currently screens at market cap $378.5M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the ANGO and IR stock pages for the full models.
Not investment advice.